Cargando…
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19
The COVID-19 pandemic has dealt a devastating blow to healthcare systems globally. Approximately 3.2% of patients infected with COVID-19 require invasive ventilation during the course of the illness. Within this population, 25% of patients are affected with neurological manifestations. Among those w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929831/ https://www.ncbi.nlm.nih.gov/pubmed/33653852 http://dx.doi.org/10.1136/bcr-2020-239781 |
_version_ | 1783659992020156416 |
---|---|
author | Roy, Devjit Song, Justin Awad, Nirvana Zamudio, Paul |
author_facet | Roy, Devjit Song, Justin Awad, Nirvana Zamudio, Paul |
author_sort | Roy, Devjit |
collection | PubMed |
description | The COVID-19 pandemic has dealt a devastating blow to healthcare systems globally. Approximately 3.2% of patients infected with COVID-19 require invasive ventilation during the course of the illness. Within this population, 25% of patients are affected with neurological manifestations. Among those who are affected by severe neurological manifestations, some may have acute cerebrovascular complications (5%), impaired consciousness (15%) or exhibit skeletal muscle hypokinesis (20%). The cause of the severe cognitive impairment and hypokinesis is unknown at this time. Potential causes include COVID-19 viral encephalopathy, toxic metabolic encephalopathy, post-intensive care unit syndrome and cerebrovascular pathology. We present a case of a 60 year old patient who sustained a prolonged hospitalization with COVID-19, had a cerebrovascular event and developed a persistent unexplained encephalopathy along with a hypokinetic state. He was treated successfully with modafinil and carbidopa/levodopa showing clinical improvement within 3–7 days and ultimately was able to successfully discharge home. |
format | Online Article Text |
id | pubmed-7929831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-79298312021-03-19 Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 Roy, Devjit Song, Justin Awad, Nirvana Zamudio, Paul BMJ Case Rep Case Report The COVID-19 pandemic has dealt a devastating blow to healthcare systems globally. Approximately 3.2% of patients infected with COVID-19 require invasive ventilation during the course of the illness. Within this population, 25% of patients are affected with neurological manifestations. Among those who are affected by severe neurological manifestations, some may have acute cerebrovascular complications (5%), impaired consciousness (15%) or exhibit skeletal muscle hypokinesis (20%). The cause of the severe cognitive impairment and hypokinesis is unknown at this time. Potential causes include COVID-19 viral encephalopathy, toxic metabolic encephalopathy, post-intensive care unit syndrome and cerebrovascular pathology. We present a case of a 60 year old patient who sustained a prolonged hospitalization with COVID-19, had a cerebrovascular event and developed a persistent unexplained encephalopathy along with a hypokinetic state. He was treated successfully with modafinil and carbidopa/levodopa showing clinical improvement within 3–7 days and ultimately was able to successfully discharge home. BMJ Publishing Group 2021-03-02 /pmc/articles/PMC7929831/ /pubmed/33653852 http://dx.doi.org/10.1136/bcr-2020-239781 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Case Report Roy, Devjit Song, Justin Awad, Nirvana Zamudio, Paul Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 |
title | Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 |
title_full | Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 |
title_fullStr | Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 |
title_full_unstemmed | Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 |
title_short | Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19 |
title_sort | treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with covid-19 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929831/ https://www.ncbi.nlm.nih.gov/pubmed/33653852 http://dx.doi.org/10.1136/bcr-2020-239781 |
work_keys_str_mv | AT roydevjit treatmentofunexplainedcomaandhypokineticrigidsyndromeinapatientwithcovid19 AT songjustin treatmentofunexplainedcomaandhypokineticrigidsyndromeinapatientwithcovid19 AT awadnirvana treatmentofunexplainedcomaandhypokineticrigidsyndromeinapatientwithcovid19 AT zamudiopaul treatmentofunexplainedcomaandhypokineticrigidsyndromeinapatientwithcovid19 |